FutureCeuticals® Research Summary — Explanation of Results

Brent Hicks - Chief Executive Officerby Brent Hicks - Chief Executive Officer
August 13, 2010   |   6:28 pm

FutureCeuticals® Research Summary — Explanation of Results

The second phase of ex vivo studies with FutureCeuticals® is now complete.  In order to help you better understand the significant scientific importance of these exciting results, below are some definitions of terms as well as a summary of findings.

DEFINITION OF TERMS:

Ex vivo: Tests performed ex vivo (Latin: out of the living) take place outside an organism but can be performed in or on tissue—in our case, on human blood cells—with the minimum alteration of natural conditions.

Bioactivity: Bioactivity refers to the specific effect on, or a reaction in, living animal or plant tissue upon exposure to a substance., i.e. happenings inside cells.

Oxygen Metabolism: Oxygen Metabolism is one of the key ways a cell burns fuel to produce useful energy. It is a set of the metabolic reactions and processes the body uses to convert biochemical energy from nutrients into Adenosine Triphosphate (ATP).

ATP and ADP: ATP or Adenosine Triphosphate (Tri- means 3) is a coenzyme used as the main energy storage and transfer molecule in the cells of all known organisms. ATP breakdown to ADP or Adenosine Diphosphate (Di- means 2) releases effective energy the cell uses in its every activity, including just staying alive. This is a constant process. The rapid breakdown and rebuilding of ATP provides the rapid energy transfer required for efficient cellular activities including growth, reproduction and healing.

Krebs Cycle: The Krebs Cycle refers to a complex series of chemical reactions in all cells that utilize oxygen as part of their respiration process. The Krebs Cycle is ongoing in the human body.

Free Radicals: Free Radicals are molecules responsible for aging, tissue damage, and many diseases. They are unstable and must bond with other molecules, thereby destroying their vigor and perpetuating the detrimental process.

Lactic Acid: Lactic Acid is the by-product of the anaerobic energy pathway, or glycolysis, whereby ATP is produced from carbohydrate metabolism.  Lactic Acid provides fuel for tissues and liver production of glucose and glycogen, and helps use dietary carbohydrates. Too much of it, however, can interfere with electrical signals in the muscles and nerves, slowing energy reactions and causing undesirable physiological behavior.
-
ROS: ROS (reactive oxygen species). are chemically-reactive molecules containing oxygen. During times of environmental stress, ROS levels can increase dramatically. This can result in significant damage to cell structures.

SUMMARY OF FINDINGS:

The Archaea Active™ formula produced measurable ex vivo bioactivity when subjected to FutureCeuticals® bio-analytical platform.

The ex vivo research performed by FutureCeuticals® verified that the Archaea Active™ formula stimulated oxygen metabolism and increased ATP production. More importantly, the formula increased oxygen metabolism and ATP production without undesirable increases in lactic acid levels or free radical production. Researchers are not aware of any other supplement or formula, to date, that has the same potential benefits without these negative effects.

FutureCeuticals® TargeTest™ results have shown to date:

1.    The Archaea Active™ formula stimulated intracellular oxygen metabolism within fresh, viable human blood cells from multiple donors.
2.    The Archaea Active™ formula increased intracellular ATP  production within fresh, viable human blood cells from multiple donors.
3.    As intracellular ATP production went up, intracellular ADP production went down. This is desirable, healthy Krebs Cycle activity.
4.    Observed increases of intracellular ATP within blood cells were not accompanied by inordinate increases in intracellular lactic acid within fresh human blood cells.

5.    Observed increases in intracellular ATP and oxygen metabolism within blood cells were not accompanied by increases in intracellular HORAC (hydroxyl free radicals) or intracellular ROS (reactive oxygen species).

FutureCeuticals® expects to publish its first scientific paper containing details of this exciting research this fall. The next phase of testing, also scheduled to commence this fall, will include acute human clinical studies.  These will be followed by a larger placebo con¬trolled human clinical study utilizing a double blind method at the end of 2010 or beginning of 2011.

About FutureCeuticals®

FutureCeuticals® is a vertically integrated bio-technology company and raw material supplier specializing in the discovery, development, manufacturing, processing, growing, and marketing of scientifically innovative nutraceuticals, functional foods, probiotics and cosmetic ingredients. The company’s state-of-the-art facilities cover over 2 million square feet of manufacturing space, and include manufacturing locations in Illinois, Wisconsin, California and Europe, as well as a new bio-research laboratory facility in Irvine, California. The facilities encompass full-production and scale-up lines, two quality assurance labs, an HPLC, TLC, GCMS, FTIR reference lab, and a knowledgeable staff of doctoral-level scientists. The Company processes over 60 million pounds of non-GMO fruit, vegetable and grain-based ingredients every year. Privately held and family-owned, FutureCeuticals® is a sister company to Van Drunen Farms (www.vandrunenfarms.com). More information is available at www.futureceuticals.com.

About EvolvHealth, LLC.

EvolvHealth is a direct sales consumer health company headquartered in Dallas, Texas. Its purpose is to help people improve their family’s physical and financial well-being through science-driven products and entrepreneurial opportunities. To learn more about Evolv or become a distributor of the Evolv product, go to www.evolvhealth.com.

This document is for U.S. Distribution only. If distributed, it must be reproduced in its entirety.

# # #

To print off a high resolution pdf version of this press release, click here.

  • Share/Bookmark

Continue »

FutureCeuticals® Research of Archaea Active™ Results in Unprecedented Endorsement

Brent Hicks - Chief Executive Officerby Brent Hicks - Chief Executive Officer
August 6, 2010   |   3:32 pm

FOR IMMEDIATE RELEASE – AUGUST 9, 2010

FUTURECEUTICALS® RESEARCH OF ARCHAEA ACTIVE™ RESULTS IN UNPRECEDENTED ENDORSEMENT

Dallas, TX — EvolvHealth, LLC is pleased to announce an update on the continued research of the Archaea Active™ formula being conducted by FutureCeuticals®. The second phase of studies, which included ex vivo bioactivity testing of the formula, demonstrated that Archaea Active™ promoted oxygen metabolism and increased ATP production with no associated undesirable increases in lactic acid levels or free radical production. Researchers are not aware of any other supplement or formula, to date, that has the same potential benefits with no known negative effects.

“Increased oxygen uptake without the side effects connected to lactic acid or free radical production is a breakthrough,” says Dr. Newman, renowned researcher.

The ex vivo testing was conducted by FutureCeuticals® using Seahorse Technology as well as their branded TargeTest™ protocol. The Archaea Active™ formula produced measurable ex vivo bioactivity when subjected to the bio-analytical platform.

John M. Hunter, General Manager of FutureCeuticals®, recently announced that due to the continued positive discoveries surrounding research of the Archaea Active™ formula, FutureCeuticals® can now officially endorse the Archaea Active™ proprietary formula found within the Evolv product for its demonstrated ex vivo bioactivity.

“For the first time in our history, we are awarding the FutureCeuticals® TargeTest™ seal of approval to a product we do not manufacture,” said Mr. Hunter. “We have been consistently impressed with the way the Archaea Active™ formula has provided encouraging results while being subjected to the most rigorous, cutting-edge bio-analytical screenings available. As we execute our very carefully designed bio research on Archaea Active™, we look forward to moving into the clinical setting with this technology.”

EvolvHealth, LLC – Committed to Helping People “Evolv”
Trey White, Chairman and Co-Founder of EvolvHealth, LLC says, “With years of product consumption and thousands of anecdotal testimonials behind it, the Archaea Active™ formula was clearly a special product. We are excited about the results from the latest study and are elated that the continued research is confirming what testimonials have been reporting for many years. The FutureCeuticals endorsement of the Archaea Active’s ex vivo bioactivity is further proof that the Archaea Active technology is not only unique but a breakthrough technology.”

About Dr. Robert Newman
Dr. Robert Newman, a renowned medical researcher and Professor Emeritus at The University of Texas M.D. Anderson Cancer Center in Houston, has agreed to consult in regards to further testing of the proprietary Archaea Active™ formula. Dr. Newman, currently Chief Science Officer (CSO) at a major New England nutraceutical company, will advise on future testing procedures, as well as review and analyze test results from outside independent labs.

Dr. Newman’s career has been dedicated to the development of novel therapeutic strategies to improve the quality of life for patients with inflammatory and malignant diseases. His research efforts in several scientific disciplines are nationally recognized, including in the fields of pharmacology, analytical chemistry, drug development, and clinical pharmacology. His work has resulted in more than 300 peer-reviewed publications.

About FutureCeuticals®
FutureCeuticals® is a vertically integrated bio-technology company and raw material supplier specializing in the discovery, development, manufacturing, processing, growing, and marketing of scientifically innovative nutraceuticals, functional foods, probiotics and cosmetic ingredients. The company’s state-of-the-art facilities cover over 2 million square feet of manufacturing space, and include manufacturing locations in Illinois, Wisconsin, California and Europe, as well as a new bio-research laboratory facility in Irvine, California. The facilities encompass full-production and scale-up lines, two quality assurance labs, an HPLC, TLC, GCMS, FTIR reference lab, and a knowledgeable staff of doctoral-level scientists. The Company processes over 60 million pounds of non-GMO fruit, vegetable and grain-based ingredients every year. Privately held and family-owned, FutureCeuticals® is a sister company to Van Drunen Farms (www.vandrunenfarms.com). More information is available at www.futureceuticals.com.

About EvolvHealth, LLC.
EvolvHealth is a direct sales consumer health company headquartered in Dallas, Texas. Its purpose is to help people improve their family’s physical and financial well-being through science-driven products and entrepreneurial opportunities. To learn more about Evolv or become a distributor of the Evolv product, go to www.evolvhealth.com.

Contact:
Anne Bodak Smith, VP of Sales, EvolvHealth, LLC
P: 888.280.9555 F: 972.392.4219
E: media@evolvhealth.com

http://www.evolvhealth.com

*ex vivo refers to experimentation or measurements done in or on fluids or tissue in an artificial environment outside the organism with the minimum alteration of natural conditions. Ex vivo conditions allow experimentation under a more controlled environment than is possible in the intact organism.

Archaea Active™ and Cellular O2 On Demand™ are trademarks of Health2o Products, LLC under license by EvolvHealth, LLC. FutureCeuticals® and the TargeTest™ seal of approval are registered trademarks of VDF FutureCeuticals, Inc., used under license.

This document is for U.S. Distribution only. If distributed, it must be reproduced in its entirety.

# # #

To print off a high resolution pdf version of this press release, click here.

  • Share/Bookmark

Continue »

Why Evolv is just what the Doctor ordered!

Anne Bodak Smith - VP of Salesby Anne Bodak Smith - VP of Sales
June 16, 2010   |   3:45 pm

Join us tonight to hear what Health Care Professionals have to say about Evolv and its Archaea Active formula. This is the perfect call for your Members and Customers who still have questions about how Evolv could benefit them.

Special guests include:

Executive Director Dr. Tanya Baldwin M.D.

Dr. Tanya R. Baldwin, M.D. is a board certified family practitioner residing in the Toledo, OH area. She attended the University of Toledo Medical College formerly known as Medical College of Ohio. She did her residency training at Mercy Family Practice in Toledo, OH. Dr. Baldwin has a very active clinical practice in which she primarily serves uninsured, under-insured and underprivileged patients. She has special interests in womens and childrens Health and in Integrative Medicine. As such, Dr. Baldwin has served as a spokesperson for a natural weight loss product line. She speaks at various community workshops, seminars and health fairs. Dr. Baldwin serves as a guest columnist for various newspapers and magazines. Dr. Baldwin is a proud member of the American Academy of Family Practice, the Ohio Academy of Family Practice and the National Medical Association. She is also a proud wife and mother to three daughters.

Senior Executive Dr. Karen Kelley D.C., N.D.

Dr. Kelley is the Director of the Holistic Healing Arts Center in Foley, AL (near Gulf Shores) and has been in the field of Complimentary Medicine for the past 35 years. She is a Chiropractor, Naturopathic Physician, Psychotherapist, Acupuncturist and Clinical Nutritionist. She is also a certified Animal Chiropractor through the American Veterinary Chiropractic Association where she has taught Small Animal Nutrition and Applied and Clinical Kinesiology for their diplomat program. She lectures and facilitates workshops throughout the country in the fields of holistic health, women’s issues, psycho- spiritual counseling and natural health care for animals. As a Doctor of Chiropractic, she is licensed to diagnose and treat neuro-musculoskeletal disorders in humans with specialty training and certification in animal chiropractic.

Executive Director Dr. Ken Collins DDS (Oral Surgery & Maxillofacial Surgery)

Dr. Collins graduated from Meharry College in Nashville, TN and completed his residency in Oral & Maxillofacial Surgery in Washington, DC at the Howard University Hospital and its affiliates DC General Hospital, and the DC VA Hospital. He currently resides in McDonough, GA and has two practices in Fayetteville, GA and Lithonia, GA. His practice offers a full scope of Oral & Maxillofacial Surgeries including dental and facial implants, pathology, 3rd molar and complicated extractions, surgical orthodontics, infections, facial trauma, facial cosmetics and general and intravenous anesthesia. Dr. Collins has been married to his wife Deidrea for 15 years and has four beautiful children: Kenneth III, Ciarra, Kennedy, and Camryn.

Invite your team and your customers for this informative call so you can become one step closer to receiving two free cases of Evolv with our Preferred Customer promotion!

Wednesday, June 16, 2010
9:30pm ET, 8:30pm CT, 7:30pm MT, 6:30pm PT
712 338-8186 PIN 965055#

  • Share/Bookmark

Continue »

More John Hunter video clips

Jonathan Gilliam - Chief Marketing Officerby Jonathan Gilliam - Chief Marketing Officer
May 28, 2010   |   8:47 am

For all you John Hunter fans, we’ve posted the final clips from his session at the Evolv 2010 Summit. Subscribe to Evolv’s YouTube Channel to watch the rest of John’s great presentation.

  • Share/Bookmark

Continue »

John Hunter explains importance of mitochondrial health

Jonathan Gilliam - Chief Marketing Officerby Jonathan Gilliam - Chief Marketing Officer
May 19, 2010   |   4:04 pm

Following up on our post of a fantastic video on the science behind Evolv, we continue with new video clips from the on-stage presentation from FutureCeutical’s John Hunter at the Evolv 2010 Summit.

In this clip, Mr. Hunter explains what the “mitochondria” in your body do and why oxygen uptake at the cellular level is so critical to mitochondrial health.

  • Share/Bookmark

Continue »

John Hunter explains the science behind Evolv

Jonathan Gilliam - Chief Marketing Officerby Jonathan Gilliam - Chief Marketing Officer
May 12, 2010   |   4:19 pm

We all agree that when we drink Evolv we feel better. We also agree that we’d love for everyone we know to be drinking Evolv so they can feel better too. But how does Evolv work the way it does?

The good news is that you and I need not become experts in molecular biology in order to share Evolv. We just share it, people feel it and get excited about what they feel. Trey has invested millions of dollars in research to provide you with even more confidence in this amazing product, and to develop new ones to further enrich your health and your income.

Those of you who attended the 2010 Summit will recognize John Hunter, VP and General Manager of FutureCeuticals, Inc., our product research and development partner currently researching multiple facets of the ArchaeaActive solution. In this post is the first of four clips from the 2010 Summit of John Hunter explaining the science behind Archaea Active and the research platform we are building to examine how it works.

FutureCeuticals is planning to release their first study on Evolv this year. Thank you John Hunter for your fantastic presentation the Summit.  Share this video with friends, play it at your next PER, and get a better sense of why Evolv makes you feel the way you do.

  • Share/Bookmark

Continue »

Science behind Evolv is helping the Gulf oil spill

Jonathan Gilliam - Chief Marketing Officerby Jonathan Gilliam - Chief Marketing Officer
May 11, 2010   |   5:05 pm

Several Members have asked if 60354152EvolvHealth and Health2o Products, manufacturer of the Archaea Active™ formula, are doing anything for the Gulf oil spill.

If you are familiar with the history of our bio-catalyst, you will remember that the Archaea Active™ formula was originally created for bioremediation — cleaning up contamination using live organisms. It was this concept of positive biological stimulation that was manipulated over several years to include only food-grade ingredients, thereby making it safe for human consumption.

The original bio-catalyst is one of several ingredients in a product called PowerClean, to be used in the Gulf clean-up.  PowerClean has long been listed on the EPA National Contingency Plan Product Schedule.  The patented formula also includes a blend of surfactants and microbes that perform a variety of tasks in contamination cleanup.  Integra Environmental has received an initial order for 10,000 gallons of the PowerClean water treatment to test on the spill.

Of course, PowerClean is not the same product as your all-natural Evolv; rest assured we won’t be pouring gallons of Evolv into the Gulf of Mexico. You can be proud, though, that the science that originated the Archaea Active™ formula is aiding in the cleanup efforts.

  • Share/Bookmark

Continue »

Earth day, is it just another date on the calendar?

Jonathan Gilliam - Chief Marketing Officerby Jonathan Gilliam - Chief Marketing Officer
April 26, 2010   |   4:13 pm

Hey Evolvers!Evolv_Recycle

Last week we celebrated Earth Day. So, what did you do on Earth day?  What does it mean to you?

We want to make sure you know that at Evolv, everyday is Earth day!  Whether it’s our commitment to recycling, or our fundamental belief in stewardship of all of our resources, together let’s keep the awareness alive. Our goal as a company from the very start has been one of contributing to people in every aspect of their lives.  The water bottles we use to package the Evolv Enhanced Water Beverage are BPA free and in the coming months you will hear initiatives that we are rolling out to ensure that EvolvHealth will be on the forefront of resource stewardship – in an holistic sense.  Each one of us has been blessed with resources of time, talent and treasure.

How are you stewarding your time?  Are you using effective and efficient time management systems to get the most out of your day?  Are you in control of your day or is your day in control of you?

How are you stewarding your talent?  We’ve all been gifted talents in different areas of life?  Are you using yours to your full potential?

How are you stewarding your treasure?  Riches come to us in many ways and forms.  Still, it is up to us to steward them wisely.

Time, talent and treasure.   At Evolv, we want to help each member become better stewards, and have tremendous global impact.  As you advance your Evolv business, you are impacting yourself, your family, your community, your world.  It all starts with you!

How are you Evolving today? Let us know!

  • Share/Bookmark

Continue »

iVolv Mobile for the iPhone now available

Jonathan Gilliam - Chief Marketing Officerby Jonathan Gilliam - Chief Marketing Officer
April 15, 2010   |   6:09 pm

iVOLV MobileWait til you see this!

We are proud to announce the iVOLV Mobile iPhone App has won final approval from Apple and is now available for download to your iPhone!*

How many times have you shared your Evolv story with someone, perhaps on a plane or in a store, and said to yourself, “If only I could sign them up right now!”? Or maybe you’ve been on the road and needed desperately to check your back office, but you weren’t near a computer.

 Now you can do all that and more with the new iVOLV iPhone App from EvolvHealth. To watch it in action, see a quick Demo.

How do I get it?
There are two ways to download the iVOLV iPhone App to your phone:

From your iPhone:

Launch the ‘App Store’ program on your iPhone. Use the Search Bar at the top to search for Evolv.  The iVOLV Mobile iPhone App should appear and you can download it directly to your iPhone.  

From your computer:

Open iTunes on your computer and go to the iTunes Store.  Use the Search Box in the upper right corner to search for Evolv.  To filter the results, click on ‘Apps’ under ‘Filter By Media Type’.  You should see the iVOLV Mobile iPhone App in the search window.  Click the icon to download.  Once downloaded, you can sync it to your phone.  

To Activate your iVOLV iPhone App:

Go to the myBizCenter section of your Premier eCenter.  There is a new tab called ‘iVOLV App’.  Navigate to that tab and read about the features and benefits of the iVOLV Mobile iPhone App. Once you make your decision click ‘Activate your iVolv App!’.         

Special thanks to CIO Justin White who spearheaded this effort!  If you have any questions feel free to call Evolv Member Services.

*Important notes:
1) Please note that you must have the Premier eCenter subscription. The iPhone App is $19.95 per year in addition to your monthly Premier eCenter subscription.
2) You must use your Member e-number when logging into the iVOLV iPhone App.
3) When signing up a Member, answering calls or text messages will cause you to lose the data you have already entered and will have to start over.

  • Share/Bookmark

Continue »

Ken Dunn & Partners Choose EvolvHealth

Jonathan Gilliam - Chief Marketing Officerby Jonathan Gilliam - Chief Marketing Officer
March 5, 2010   |   10:11 am

Ken Dunn pic

Developer and marketer of science-driven health products announced today the addition of Mr. Ken Dunn and his business partners, all top earners in the network marketing industry.

Dallas, TX March 5, 2010 – EvolvHealth, LLC developer and marketer of science-driven health products, announced today the addition of Mr. Ken Dunn and his business partners, all top earners in the network marketing industry. Mr. Dunn’s group represents a global community of tens of thousands of individuals focused on improving the quality of its members’ lives while instilling leadership values. After a thorough review of more than 100 companies, Mr. Dunn’s team has chosen to join EvolvHealth.

“The addition of Ken and his colleagues to the Evolv team is a tremendous win for the company and our Members,” said EvolvHealth founder Trey White. “Our team brings a sizable organization focused on developing new leaders at all levels and making a positive difference in people’s health through our products. Their belief in strong character and ethics perfectly aligns them with our ‘give, share, Evolv’ culture.”

  (read more…)

  • Share/Bookmark

Continue »

Silly comparison, but still interesting

Jonathan Gilliam - Chief Marketing Officerby Jonathan Gilliam - Chief Marketing Officer
February 11, 2010   |   1:02 pm

6064_SingleBottle_Sweating_FnlSmall transI always hesitate to compare Evolv and Archaea Active with any bottled water. As you know Evolv has a real human benefit far beyond water, and there really is no comparison. As a daily reader of amazing testimonials from our consumers  I can tell you first hand this product helps a lot of people, every day.

But we still use Evolv like a bottled water, right? So just for fun, think of most store-bought bottled water. Dasani? AquaFina?  Not naturally-sourced. It is much easier to just treat tap water for the volumes they produce than it would be to bottle water at a natural source. I promise you the Coca-Cola company is not sourcing Dasani anywhere near a mountain stream.

In Evolv’s case, the water is sourced at the edge of the Ouachita National Forest, many miles from population or agriculture centers. There it is delivered from a hearty aquifer, in its purest form. Before the Archaea Active is added, the water it is filtered far beyond what is required or what is typical of other bottled waters.

Of course, no store-bought waters contain Archaea Active, making comparisons with Evolv frivolous at best. But I love knowing the water that serves to deliver the Archaea Active ingredient to my body also happens to be one of the best waters I can drink.  ~jg

  • Share/Bookmark

Continue »

EvolvHealth’s manufacturer signs multi-year, multi-million dollar research agreement

Trey White - Founder and Chairmanby Trey White - Founder and Chairman
January 12, 2010   |   5:22 pm

FutureCeuticalsGreat news! Health2o Products LLC, our manufacturing partner, just signed a multi-year, multi-million dollar research and product development agreement with FutureCeuticals Inc. The agreement represents the next phase of research and is a significant investment in the science of the Archaea Active solution. This represents another step in our long-range plans to provide science-backed products to the direct marketing industry.

FutureCeuticals will serve as our research and product development partner as we explore various methods of delivery for the Archaea Active solution. This relationship will enable Evolv to leverage decades of experience in manufacturing health-related products, lending further credibility to Archaea Active. Read on for more info from the Health2o team.

From the Heath2o Products LLC website:

DALLAS, TX (January 5, 2010)—FutureCeuticals®, an internationally respected bio-technology firm, has signed a multi-year, multi-million dollar Cooperative Research and Development Agreement with Health2o Products, LLC of Dallas. Known for their innovations in research and development of consumer health and nutritional products, FutureCeuticals agreed to conduct research on production optimization of the Health2o Archaea Active™ formula and proprietary manufacturing processes. In addition, they will complete extensive, long-range scientific analysis and studies in clinico for the Archaea Active products currently being manufactured and in development by Health2o Products.

Initial product research and in vitro testing has supported the scientific promise of Health2o’s all natural Archaea Active formula. It is believed that the Archaea Active formula is involved with specific cell signaling processes that stimulate other cells to take human health protective responses.

“The preliminary in vitro tests conducted last year suggest that our Archaea Active formula stimulates cellular oxygen uptake and utilization, and may also possess similar metabolic properties as those compounds traditionally associated with healthy inflammatory responses.” said Kevin D. Kuykendall, Chairman and CEO of Health2o Products, LLC. “FutureCeuticals’ research will contribute to our goals for optimizing our technology platform and manufacturing processes. We selected FutureCeuticals because of their experience, specialized manufacturing knowledge, and innovative scientific research and development techniques.”

At the direction of Health2o, FutureCeuticals will initiate advanced chemistry and bio-testing protocols utilizing high-tech analytical tools and published methods. The range of research goals include chemical and physical characterization of the active components within the Archaea Active formula, as well as ex vivo screening followed by exploratory clinical studies to identify its effect and functionality in humans. Studies will target cellular regeneration, oxygen and energy metabolism, and inflammatory responses.

“We quickly recognized that Health2o has assembled a dynamic and talented group of people, and their Archaea Active technology is showing great promise.” said John M. Hunter, General Manager of FutureCeuticals. “We’re excited to have the opportunity to integrate our manufacturing capabilities, scientific knowledge, and experience into the Health2o effort—from the sourcing and standardization of raw materials and the optimization of production methodologies, to the implementation of a rigorous inter-disciplinary program of bio-research designed to support products based only upon relevant and repeatable science.”

FutureCeuticals has a long and distinguished track record in developing, manufacturing, and launching its own consumer health products, as well as hundreds of nutritional supplement and functional food ingredients used by many other manufacturers of nutrition and health-based products. They have collaborated with many major international companies in the research and development of dozens of consumer food and nutritional products in approximately 20 different product categories including baby foods, dairy products, breakfast cereals, fruit and vegetable products, and dietary supplements. Their intellectual property portfolio includes some 30 trademarked brands and over 50 patents.

Health2o recently engaged the services of Dr. Robert A. Newman, a nationally recognized nutritionist and scientist, to serve as a consultant and work closely with the selection, design, analyses, and interpretation of analytical and pharmacology studies to be performed by the scientists at FutureCeuticals. “I look forward to the careful, in-depth research of this fascinating product in order to understand its full potential in the support of human health.” said Dr. Newman. “The level of interaction and cooperation between Health2o and FutureCeuticals in fully exploring the science and promise of the Archaea Active product is to be applauded.”

  • Share/Bookmark

Continue »

The Moran’s think Evolv is the next Gatorade

Jonathan Gilliam - Chief Marketing Officerby Jonathan Gilliam - Chief Marketing Officer
December 9, 2009   |   4:19 pm

Evolv Senior Executives Jeri and Dave Moran, Atlanta, GA, share why they joined Evolv and how they help their Evolv team succeed!

Jeri and Dave Moran“There were three factors that got us to sign up right away with Evolv: the product, the leadership team, and the timing. We had been approached by other Network Marketing opportunities but everything was right with Evolv. They had a product that was new to the market. To us it was the next Gatorade and we wanted to be involved with something that exciting early on! We were really impressed with the leadership team that started the company, the financial backing and the proven leadership of many of its Members early on. I haven’t seen another product launch quite like this one that has been so socially network driven. On all fronts Evolv is a total game changer in the Network Marketing industry.

We are very committed to our team’s success and we’ve worked really hard to systematize the marketing for our team using Evolv’s marketing materials as well as some of our own. We have weekly calls with our downline and are focused on providing them support. Our team philosophy is “just do it”! We help our team understand that if they follow the model, they will be successful. We’re excited to be involved with something that has a chance to be huge!”

Team Moran will be hosting an Evolv Soiree in Atlanta, GA on Thursday, January 21st, 2010. For more information on their event and many others, please visit:  www.evolvquarterly.com.

  • Share/Bookmark

Continue »

NATIONALLY-RECOGNIZED CANCER RESEARCHER TO ADVISE HEALTH2O PRODUCTS

Trey White - Founder and Chairmanby Trey White - Founder and Chairman
December 7, 2009   |   4:41 pm

GREAT news!  Announced today from our friends at Health2o Products, our manufacturing partner.

Nationally-Recognized Cancer Researcher to Advise Health2o ProductsDr. Robert Newman

DALLAS, TX (December 7, 2009)—Dr. Robert Newman, a renowned medical researcher and Professor Emeritus at The University of Texas M.D. Anderson Cancer Center in Houston, has agreed to consult with Health2o Products, LLC in regards to further testing of its Archaea Active™ formula.

Dr. Newman, currently Chief Science Officer (CSO) at a major New England nutraceutical company, will advise on future testing procedures and review and analyze test results from outside independent labs selected by Health2o.

Dr. Newman’s career has been dedicated to the development of novel therapeutic strategies to improve the quality of life for patients with inflammatory and malignant diseases. His research efforts are nationally-recognized, and have been accomplished through several scientific disciplines, including pharmacology, analytical chemistry, drug development and clinical pharmacology. His work has resulted in more than 300 peer-reviewed publications.

Dr. Newman recently retired from M.D. Anderson, following a 24-year career there and over 30 years in academic medicine. At M.D. Anderson, he served as the Founder and Co-Director of the Pharmaceutical Development Center. Dr. Newman obtained his M.S. and Ph.D degrees in Pharmacology and Toxicology from the University of Connecticut. He was a member of the University of Vermont Medical School for seven years and was later recruited to be head of the Section of Pharmacology at M.D. Anderson where was promoted to Professor in 1991 with tenure.

“We are very pleased that Dr. Newman has signed a consulting agreement with us to serve as a Senior Advisor. He will be assisting our company in developing a road map for the continuing research and analysis of our Archaea Active™ formula,” said Kevin D. Kuykendall, chairman and CEO of Health2o Products, LLC.

  • Share/Bookmark

Continue »

Got a testimonial? Do it right and protect your business.

Jonathan Gilliam - Chief Marketing Officerby Jonathan Gilliam - Chief Marketing Officer
October 29, 2009   |   1:53 pm

Hey folks! The stories about the Evolv product are already pouring in. We knew it would happen! Keep them coming!

However, PLEASE, please, send any health-related comments and stories directly to experience@evolvhealth.com and do not publish anywhere else, otherwise you may jeopardize your business. When we receive to our email, we can have our legal eagles review them to be sure we comply with what are very strict regulations about medical claims. We may contact you after that to discuss how we can get your story out but stay within guidelines. (Posts to Facebook and Evolv web properties outside the guidelines will be deleted.)

We (and you per your distributor agreement) are prohibited from publishing health claims beyond what you see on our web site. This is very important and you will continue to hear this from us again and again.

Lastly, protect your business by reporting unapproved health claims when you see them on the Internet and elsewhere. If we work together, we can reduce regulatory risk, help others and continue to build a great business with this amazing product.

We truly appreciate everyone’s enthusiasm about Evolv.

  • Share/Bookmark

Continue »

Next >>

SEO Powered by Platinum SEO from Techblissonline